Ontario is piloting a social prescribing program based on a similar offering in the U.K., which has reduced visits to doctors and lowered participants' anxiety levels. Is it a good idea and should it be incorporated into workplace wellness programs?

View poll archives

Emerging & global markets

Given sharp dips in oil, is it a buy for Canadian pension plans?

Four investment themes for a turbulent 2019

2018 Top 40 Money Managers Report: The Trump effect

Emerging markets showing greater signs of economic stability

More emerging & global markets

Economist says no recession looming

Developing ESG, infrastructure considerations for investors in Asia

OMERS Ventures opens new office in San Francisco

Top 10 investment stories of 2018

OMERS invests in Australian offices, PSP sells animal tech company

Heading into 2019, geopolitics continue to shadow markets

Caisse launches infrastructure co-investment platform in Colombia

CPPIB looks to cash in on ‘disruption’ and shifts in technology, demographics

IMCO appoints senior managing director of private markets

AIMCo takes stake in Spanish renewable power producer

Should institutional investors buy Japan’s stocks while they’re cheap?

PSP Investments sells off Paris office building

DB pension returns power through a difficult autumn

Ivanhoé Cambridge launches joint venture in Brazilian logistics real estate

With a new leader, is Brazil open for business or more volatile?

2017 Top 40 Money Managers

Join us on Twitter

Must Read

Benefits Canada Newsletter

Connect

Conferences